Mechanistic Study of EBV mRNA Vaccine (WGc-043) in EBV-Positive Relapsed/Refractory Lymphoma

NCT06788600 · clinicaltrials.gov ↗

NOT_YET_RECRUITING

Status

15

Enrollment

OTHER

Sponsor class

Conditions

Epstein-Barr Virus Associated Lymphoma

Interventions

DRUG: EBV mRNA vaccine (WGc-043)

Sponsor

Ruijin Hospital